Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Baxter International Inc Wins Conditional EU Clearance For Gambro Takeover-Reuters


Monday, 22 Jul 2013 11:32am EDT 

Reuters reported that Baxter International Inc has secured EU regulatory approval on Monday for its proposed $4 billion acquisition of Swedish peer Gambro AB after pledging to divest a unit to allay competition concerns. The European Commission said Baxter will sell its global continuous renal replacement therapy (CRRT) business including supply deals and intellectual property rights. Reuters had flagged the EU approval on July 10. Baxter is buying Gambro from Swedish investment holding company Investor AB and its partly owned private equity company EQT. 

Company Quote

70.06
-0.35 -0.50%
30 Oct 2014